Government restates jabs commitment as regulator probes potential side-effects

Regulators are examining potential links between the Oxford/AstraZeneca vaccine and rare blood clots (Nick Potts/PA)
Regulators are examining potential links between the Oxford/AstraZeneca vaccine and rare blood clots (Nick Potts/PA)